The effect of methylphenidate on neurofibromatosis type 1: a randomised, double-blind, placebo-controlled, crossover trial

BACKGROUND: Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder with an estimated prevalence of about 1/3000, independent of ethnicity, race, or gender. Attention Deficit Hyperactivity like Disorder (ADHD)-like characteristics are often reported in patients with NF1. We hypothesised tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Lion-François, Laurence, Gueyffier, François, Mercier, Catherine, Gérard, Daniel, Herbillon, Vania, Kemlin, Isabelle, Rodriguez, Diana, Ginhoux, Tiphanie, Peyric, Emeline, Coutinho, Virginie, Bréant, Valentine, des Portes, Vincent, Pinson, Stéphane, Combemale, Patrick, Kassaï, Behrouz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4172829/
https://www.ncbi.nlm.nih.gov/pubmed/25205361
http://dx.doi.org/10.1186/s13023-014-0142-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4172829/
https://www.ncbi.nlm.nih.gov/pubmed/25205361
http://dx.doi.org/10.1186/s13023-014-0142-4

Ejemplares similares